Many startups have a great product that’s viable, marketable, and ripe with potential. But if that was the only indicator of success, then nine out of 10 startups wouldn’t fail. The annals of startup history wouldn’t be littered with instances of companies like Friendster or Color that had fantastic products, but eventually sank. The truth … Continue reading “What Is Causing Startups to Go Bankrupt?”
Category: Boston
7 Ways to Secure Your Connected Devices Against Hackers
’Tis the season for giving gifts. And increasingly, those shiny new toys and gadgets can be connected to the Internet—from TVs to watches, speakers to Barbie dolls. That Internet connection opens up a ton of possibilities for how we can use and enjoy our new devices. (“Alexa, play my Christmas playlist on Spotify, and also … Continue reading “7 Ways to Secure Your Connected Devices Against Hackers”
Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run
Biogen didn’t go far to find its new CEO. The company promoted chief commercial officer Michel Vounatsos to the top spot on Monday, succeeding former chief executive George Scangos. When Scangos announced this summer that he would step down from Biogen (NASDAQ: [[ticker:BIIB]]), the Cambridge, MA-based biotech said it would consider both internal and external … Continue reading “Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run”
As Its Rivals Team Up, Editas Buys Next-Gen CRISPR From Old Friends
[Updated 12/19/16, 5:33 p.m. ET. See below.] The two sides fighting over ownership of the landmark gene editing technology CRISPR-Cas9 are waiting for a decision from a panel of U.S. patent judges that could come early in the new year. Meanwhile, each side continues to make chess moves with their intellectual property. The latest move … Continue reading “As Its Rivals Team Up, Editas Buys Next-Gen CRISPR From Old Friends”
Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug
Slowly but surely, a new group of drugs known as “PARP” inhibitors are starting to become fixtures in the regimens for women with ovarian cancer—and perhaps more. With the approval of a drug called rucaparib (Rubraca) from Clovis Oncology, two have now been approved since 2014—and a third, from Waltham, MA-based Tesaro (NASDAQ: [[ticker:TSRO]]), could … Continue reading “Another Notch For “PARP” Blockers As FDA Approves Clovis Cancer Drug”
Xerox CTO Sophie Vandebroek Steps Down, With Eyes on Boston
An era is coming to an end at Xerox. On New Year’s Eve, Xerox will separate into two independent public companies. Its famous printing and management services side will continue to be called Xerox Corporation. Its lesser-known but large business process outsourcing operation, which handles things like healthcare claims, E-ZPass transactions, and customer care, will … Continue reading “Xerox CTO Sophie Vandebroek Steps Down, With Eyes on Boston”
Creating Bio “Gestalt” And Photos From New York Life Sciences 2021
New York City Deputy Mayor Alicia Glen said it best: “It’s about creating what I call a ‘New York gestalt’ around life sciences.” Showing that New York biotech can rise above its problems, become greater than the sum of its currently disparate parts, and create a brand that ranks up there with Wall Street, the … Continue reading “Creating Bio “Gestalt” And Photos From New York Life Sciences 2021”
Starry Scoops Up $30M as Fixed Wireless Field Heats Up
Starry, a wireless broadband startup based in Boston and New York, has raised $30 million in new equity funding, according to a regulatory filing. The investors in the round weren’t named, but the company’s previous backers include KKR, IAC, Tiger Global, and other venture capitalists. The startup is led by CEO Chet Kanojia, the founder … Continue reading “Starry Scoops Up $30M as Fixed Wireless Field Heats Up”
Boston Tech Watch: Leonardo DiCaprio, MC10, OwnerIQ, BrainCo & More
With the holidays approaching, here is what’s been going on in the local technology scene: —San Francisco-based Cloudflare acquired Eager for an undisclosed price. The Cambridge, MA-based startup says its technology makes it easier for websites to install apps and software tools. Cloudflare offers Web performance and security products and services. You can read more … Continue reading “Boston Tech Watch: Leonardo DiCaprio, MC10, OwnerIQ, BrainCo & More”
MC10 Secures $5,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9eafa715-6ff5-4a73-86b6-0118c13ecd12 Date 12/19/2016 Company Name MC10 Mailing Address 10 Maguire Road Building 3 1st Floor Cambridge, MA 02421 USA Company Description We’re MC10. It’s our mission to extend human capabilities by making high-performance electronics virtually invisible, conformal, and wearable. We reshape rigid, conventional electronics into thin, flexible devices that can stretch, bend … Continue reading “MC10 Secures $5,000,000 New Funding”
Nexamp Garners $1,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1a28bb38-11bd-4802-9d1a-85027b6ea9ca Date 12/17/2016 Company Name Nexamp Mailing Address 4 Liberty Square Boston, MA 02109 USA Company Description Nexamp is a full service clean energy solutions company. Nexamp analyzes, designs, finances, builds and maintains clean energy projects that reduce energy costs and carbon emissions for businesses, governments, and homeowners. Our solutions include renewable … Continue reading “Nexamp Garners $1,500,000 New Round”
Intrinsic Therapeutics Receives $17,877,087 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=25fd4bed-05cf-4a81-baa9-8ed5578fe366 Date 12/17/2016 Company Name Intrinsic Therapeutics Mailing Address 30 Commerce Way Woburn, MA 01801 USA Company Description The company is developing surgical equipment for use in spinal tissue repair. Website http://www.in-or.com Transaction Type Venture Equity Transaction Amount $17,877,087 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. 18 investors participated … Continue reading “Intrinsic Therapeutics Receives $17,877,087 New Financing Round”
Linkable Networks Receives $2,873,019 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f94a07cc-3df9-4d88-bcbb-ea0f634f4ca2 Date 12/17/2016 Company Name Linkable Networks Mailing Address 51 Melcher Street 1st Floor Boston, MA 02210 USA Company Description Linkable Networks is the bridge between advertisers, consumers, and financial Institutions, delivering to advertisers unprecedented accountability from online, mobile, email, print, TV, and radio advertising through online and in-store purchasing. Consumers receive … Continue reading “Linkable Networks Receives $2,873,019 New Funding”
Nokia’s Acquisition of Deepfield a Big Win for Ann Arbor’s IT Industry
Finnish telecom giant Nokia today announced it has acquired Ann Arbor, MI-based Deepfield, an IP network performance management and security startup. The terms of the deal were not disclosed. Deepfield was co-founded in 2011 by Craig Labovitz, formerly the chief scientist at Arbor Networks, a Burlington, MA-based company that grew from being a DARPA-funded research project at … Continue reading “Nokia’s Acquisition of Deepfield a Big Win for Ann Arbor’s IT Industry”
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More
The 21st Century Cures Act is now law. New York wants to play in the biotech big leagues. The FDA under Trump will have license to approve drugs faster and could have a former top official back on board as commissioner. An eye drug failed, an Alzheimer’s drug got scrutinized, and a new antibiotic passed … Continue reading “Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More”
Hippo Lands $14,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e24ea620-4b90-4f33-83b9-38bbf9fd7a1e Date 12/16/2016 Company Name Hippo Mailing Address 745 Atlantic Avenue Boston, MA 02111 USA Company Description Hippo is home insurance for the modern household. Founded in 2015 by Assaf Wand and Eyal Navon, Hippo is a first-of-its kind, entirely online home insurance product designed around the needs of the modern household. … Continue reading “Hippo Lands $14,000,000 Series A Financing”
OwnerIQ Secures $6,050,033 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a31872a0-62fb-4833-ab09-458567021180 Date 12/16/2016 Company Name OwnerIQ Mailing Address 27-43 Wormwood St 4th Floor Boston, MA 02210 USA Company Description OwnerIQ operates a network of consumer self-support Web sites for common household product categories. The company is pioneering the concept of Ownership Targeting, providing brand advertisers with highly customized programs to precisely target … Continue reading “OwnerIQ Secures $6,050,033 New Financing Round”
Amino Apps Garners $19,200,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=346e8b3f-b502-462a-8a45-59b3feb3d31b Date 12/16/2016 Company Name Amino Apps Mailing Address 469 Moody St Waltham, MA 02453 USA Company Description Express yourself, discover new friends and discuss your passion with like-minded people. Website http://www.aminoapps.com Transaction Type Venture Equity Transaction Amount $19,200,000 Transaction Round Series B Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms … Continue reading “Amino Apps Garners $19,200,000 Series B Financing Round”
BrainCo Garners $5,500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f2392afb-bbc8-4947-ac83-c3dc606a7052 Date 12/16/2016 Company Name BrainCo Mailing Address 120 Beacon St. Somerville, MA 02143 USA Company Description BrainCo was founded in February of 2015 and incubated from the Harvard Innovation Lab. The company develops portable, wireless BMI wearables, which help improve working efficiency through neurofeedback training. By July of 2016, BrainCo further … Continue reading “BrainCo Garners $5,500,000 New Financing Round”
Unilever Acquires Living Proof for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=27f488f7-0980-4597-b7b8-e1e982d153de Date 12/16/2016 Company Name Living Proof Mailing Address 301 Binney Street 1st Floor Cambridge, MA 02142 USA Company Description Living Proof, Inc. provides materials and products for hair care in the United States. It offers straight making no frizz styling sprays, creams, and treatments; and wave shaping curl defining no frizz … Continue reading “Unilever Acquires Living Proof for Undisclosed Sum”
After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another
Agios Pharmaceuticals has been developing two experimental drugs for anemia. For a couple of years, the company has said it would eventually move the better one forward and leave the other behind. As it turns out, the FDA has made the decision an easy one. Agios (NASDAQ: [[ticker:AGIO]]) said this afternoon it has scrapped AG-519, … Continue reading “After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another”
Hopper Tracks Down $50M, Goes All In on Flight-Booking App
[Corrected 12/15/16, 6:24 pm. See below.] Hopper, the maker of an app that helps consumers find and book cheap flights, could become the Boston area’s next big travel technology company. It’s certainly one of the better-funded ones, thanks to a major investment announced today. In a press release, Hopper said it has raised $82 million … Continue reading “Hopper Tracks Down $50M, Goes All In on Flight-Booking App”
Flagship Pioneers New Name, $285M ‘Special Opportunities’ Fund
Flagship Ventures is changing its name and unveiling a new $285 million side fund that will pump more money into the firm’s portfolio companies when they are ready to rapidly grow. The follow-on fund from the newly christened Flagship Pioneering will seek investment opportunities characterized by an “explosive platform with many different applications,” says Noubar … Continue reading “Flagship Pioneers New Name, $285M ‘Special Opportunities’ Fund”
Goldfinch Bio Obtains $55,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cb993698-0292-4ca6-ad79-60afe8af9202 Date 12/15/2016 Company Name Goldfinch Bio Mailing Address 215 First Street 4th Floor Cambridge, MA 02142 USA Company Description At Goldfinch, we are pioneering a new approach to discover and develop therapeutics for kidney disease that is unprecedented. Website http://www.goldfinchbio.com Transaction Type Venture Equity Transaction Amount $55,000,000 Transaction Round Series A … Continue reading “Goldfinch Bio Obtains $55,000,000 Series A Round”
Nasuni Secures $25,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d5a7398b-c6ac-4bd2-bd68-b8ba3ef40b8b Date 12/15/2016 Company Name Nasuni Mailing Address 313 Speen Street Natick, MA 01760 USA Company Description Nasuni was founded in 2009 by seasoned executives to deliver a gateway to cloud storage that makes it feasible for more business users. Website http://www.nasuni.com Transaction Type Venture Equity Transaction Amount $25,000,000 Transaction Round Undisclosed … Continue reading “Nasuni Secures $25,000,000 New Funding”
Hexadite Teams With Carbon Black & Others to Automate Cybersecurity
A new alliance between cybersecurity companies from across the U.S. aims to more tightly integrate their products and advance efforts to automate key security processes. The initiative—dubbed the Automated Security Alliance Program, or ASAP—is led by a Boston-based startup, Hexadite. Its initial group of partners includes some big names in the cybersecurity world: Carbon Black, … Continue reading “Hexadite Teams With Carbon Black & Others to Automate Cybersecurity”
Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease
Chronic kidney disease affects more than 10 percent of U.S. adults, and the risk of developing the condition increases with age. There are plenty of drugs to treat the disease’s symptoms, such as anemia, high blood pressure, and bone trouble. While these drugs can manage the signs and symptoms of the disease, they don’t cure … Continue reading “Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease”
50 Podcasts You Should Be Listening To—and 5 New Ways to Find Them
If you’re not much of a podcast listener and you have a sense that you’re missing out on a lot of great content, you’re absolutely right. But now is a good time to fix that, thanks to a new profusion of listening options. And to get you started, I have a few shows to suggest. … Continue reading “50 Podcasts You Should Be Listening To—and 5 New Ways to Find Them”
Mobiquity Receives $1,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6661ff97-c39a-40d6-8fa6-d49776a1975f Date 12/14/2016 Company Name Mobiquity Mailing Address 51 Sawyer Rd. Waltham, MA 02453 USA Company Description Mobiquity is a strategy-led, implementation driven Mobile Computing professional services firm focused on architecting, developing and deploying custom mobile solutions for the Global 2000. Mobiquity offers a broad range of services for clients seeking to … Continue reading “Mobiquity Receives $1,000,000 New Financing Round”
Proteon’s Blood Vessel Drug Flunks Main Phase 3 Test, Shares Plummet
A Proteon Therapeutics drug developed for chronic kidney disease patients has failed the key test in its late-stage clinical trial, putting the company’s shares into a tailspin. Proteon (NASDAQ: [[ticker:PRTO]]) was studying its drug vonapanitase in patients who need kidney dialysis. The Waltham, MA-based company said that compared against a placebo, its experimental drug failed … Continue reading “Proteon’s Blood Vessel Drug Flunks Main Phase 3 Test, Shares Plummet”
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan
[Updated w/comments, new information, 3:45 p.m. ET, see below] Over the last two days, city and state governments in New York have combined to commit a total of $1.15 billion to the development of the life sciences industry in the Empire State, the largest biotech bet in its history. Today is New York City’s turn. … Continue reading “NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan”
Philadelphia’s goBooze Starts Beer, Wine Delivery in Austin
Austin—This past summer had been the season of alcohol delivery startups. As we go into the year-end festivities, Philadelphia-based goBooze announced today that it has expanded service to Austin. GoBooze is the alcohol delivery arm of goPuff, a delivery service company that delivers all manner of consumer products and food that says it fulfills orders in … Continue reading “Philadelphia’s goBooze Starts Beer, Wine Delivery in Austin”
Pulse@MassChallenge Pulls Heavily From MA for First Group of Startups
[Updated 12/13/16, 9:30 am, with link to list of companies.] Today MassChallenge revealed the 31 startups chosen for the inaugural six-month session of its new Boston digital health lab, Pulse@MassChallenge, and there are a lot of familiar faces. Eight of the companies that will participate are alumni of MassChallenge’s main startup accelerator program in Boston. … Continue reading “Pulse@MassChallenge Pulls Heavily From MA for First Group of Startups”
Nasuni Downloads $25M as Large Enterprises Commit to Cloud Storage
Nasuni has scooped up another heap of cash to push its cloud storage products to more big companies around the world. Today the Natick, MA-based firm announced $25 million in new funding. That includes a $17.5 million Series E equity round led by new investor Sigma Prime Ventures, with contributions from earlier backers Flybridge Capital … Continue reading “Nasuni Downloads $25M as Large Enterprises Commit to Cloud Storage”
New York State Hatches Sprawling $650M Plan to Foster Biotech
New York Governor Andrew Cuomo announced on Monday a $650 million initiative to support the development of biotech in the state of New York, where life science businesses have had trouble for years gaining a foothold despite a strong core of biomedical research work in New York City and beyond. The plan involves three main … Continue reading “New York State Hatches Sprawling $650M Plan to Foster Biotech”
BlueRock Raises $225M To Repair Heart Damage With Stem Cells
A new stem cell therapeutics company, BlueRock Therapeutics, has launched with $225 million in funding from international healthcare giant Bayer and Versant Ventures. Using work from Nobel Prize winner Shinya Yamanaka and others, BlueRock will operate in Toronto, New York, and Boston. The company said one of its first projects aims to repair heart muscle, … Continue reading “BlueRock Raises $225M To Repair Heart Damage With Stem Cells”
The State of Cybersecurity: Photos and Takeaways
‘Tis the season to be careful. We live in uncertain times—made even more perilous by the specter of cyber attacks on every level of business. But there’s a lot that can be done to improve things. To dive deeper into the threats and opportunities, Xconomy convened the top names in cybersecurity from around Boston and … Continue reading “The State of Cybersecurity: Photos and Takeaways”
Boston Tech Watch: Cybersecurity, Drones, Silent Discos, & More
[Updated 12/12/16, 2:54 pm. See below.] It’s mid-December, and that means a rush of tech news, as companies work feverishly to get deals done before the end of the year. Recent moves in the Boston area include American Express’s purchase of a local cybersecurity startup, more funding for the new cloud storage startup from Carbonite’s … Continue reading “Boston Tech Watch: Cybersecurity, Drones, Silent Discos, & More”
San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis
Molecular Assemblies, a San Diego startup developing a new enzymatic method for synthesizing DNA, said today it has raised $2.3 million in a seed financing round. The funding will be used to hire more scientists and to advance the company’s development of enzymatic DNA synthesis technology, CEO Michael Kamdar said in an interview Friday. Molecular … Continue reading “San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis”
Vesper’s Waterproof Microphones Draw Interest from Amazon, Others
As we move toward a world where many (if not most) devices can be controlled by our voices, the ability to reliably capture those sounds becomes paramount. That spells opportunity for Vesper, a Boston-based startup that makes advanced microphone technology that could be used in smartphones, voice-controlled speakers, connected cars, and more. Investors like what … Continue reading “Vesper’s Waterproof Microphones Draw Interest from Amazon, Others”
Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song”
When Eli Lilly (NYSE: [[ticker:LLY]]) reported the day before Thanksgiving, that its Alzheimer’s treatment solanezumab failed to significantly improve the condition of people with a mild form of the disease, some observers immediately called it a final blow for the drug. After all, it had also failed to improve a broader range of patients with … Continue reading “Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song””
Smack Might Be the Future of Social Apps, But I’m Not Cool Enough
I’ve got a confession to make: I don’t get Snapchat. I consider myself a generally tech-savvy person. I own a smartphone, I know my way around your average software program or mobile app, and I’m giddily hoping Santa delivers me an Amazon Echo Dot on Dec. 25. But even though I’m a 27-year-old tech journalist, … Continue reading “Smack Might Be the Future of Social Apps, But I’m Not Cool Enough”
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More
What a week. The 21st Century Cures Act is now waiting President Obama’s promised signature after easy passage through Congress. President-elect Donald Trump re-stirred the drug-pricing pot with comments in Time Magazine and a reported FDA commissioner candidate who doesn’t seem to think much of the regulatory process. And a trio of judges met to … Continue reading “Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More”
Nantero Secures $21,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c6dbda48-eeee-4f12-a55f-e1b64cd0a8b8 Date 12/9/2016 Company Name Nantero Mailing Address 25-B Olympia Avenue Woburn, MA 01801 USA Company Description Next generation memory technology that is incredibly fast, packs massive amounts of storage and is permanently nonvolatile and is going to change the world. Installed in multiple production fabs today, Nantero’s NRAM is already being … Continue reading “Nantero Secures $21,000,000 New Funding”
LifeYield Lands New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3f5a538c-3f6e-4bd1-9698-ee54d316c3f0 Date 12/9/2016 Company Name LifeYield Mailing Address 175 Federal Street 7th Floor Boston, MA 02110 USA Company Description LifeYield is a transformative software company that helps forward-thinking financial firms, advisors, and investors make and keep more money. We do so through the Advantage Suite of asset optimizing software programs including Portfolio … Continue reading “LifeYield Lands New Funding Round”
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round
A number of companies are pursuing ways to enlist the immune system for treating cancer. Now TCR² Therapeutics is joining the ranks with technology that it says could improve on how the body’s cancer-fighting cells respond to the disease. Cambridge, MA-based TCR² has $44.5 million in new capital to further develop its technology. MPM Capital … Continue reading “TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round”
Nantero Lands $21M Financing for Its Carbon Nanotube Computer Memory
Nantero, a nanotech company building a new type of computer memory that it says is stronger than steel and less dense than aluminum, has raised $21 million in new financing. The company has now raised $110 million since its founding in 2001. Based in Woburn, MA, Nantero is using its new funding to get its … Continue reading “Nantero Lands $21M Financing for Its Carbon Nanotube Computer Memory”
Gurnet Point Invests $92M in Crossover Health to Fund Growth
Cambridge, MA-based Gurnet Point Capital has invested $92 million in Crossover Health, a six-year-old company that provides membership-based healthcare services to employers that are self-insured. The funding is intended to increase the capital available for Crossover Health’s expansion and to buy out a portion of the company’s existing shareholders, the company said. The deal enables … Continue reading “Gurnet Point Invests $92M in Crossover Health to Fund Growth”
Wake Up, Pharma—Trump Is Not Your Savior
Since the election, leaders in biotechnology and pharmaceuticals are acting like they got away with robbery. The Nasdaq Biotechnology Index went up 9 percent overnight on November 8th. With Donald Trump coming into office, the whole industry seems to have breathed a sigh of relief that the status quo—a continuous race toward higher prices—will last … Continue reading “Wake Up, Pharma—Trump Is Not Your Savior”
American Express Acquires InAuth for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=22cd6266-86fc-4f9d-a330-b7dd3789370d Date 12/8/2016 Company Name InAuth Mailing Address 867 Boylston Street Venice, MA 02116 USA Company Description InAuth offers the market s best mobile-first authentication & fraud prevention across mobile apps, mobile browsers, and desktop browsers. Website http://www.inauth.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds Purposes M&A Terms The acquisition … Continue reading “American Express Acquires InAuth for Undisclosed Sum”